Autopsy report · NCT04543916

Venetoclax and Irinotecan in Relapsed/Refractory SCLC

“AbbVie decided to stop trial involving Venetoclax for safety measures needed”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Virginia Commonwealth University

Sponsor type

University, hospital or other

Conditions

Relapsed Small Cell Lung Cancer; Refractory Small Cell Lung Carcinoma

Interventions

Venetoclax 50 MG; Venetoclax 100 MG; Venetoclax 200 MG; Venetoclax 400; Venetoclax 600; Irinotecan 60 mg/m2

Participants

0

Trials that died the same way

• A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer
  “Decision was made by Sponsor to stop the trial.” (57% match in meaning)
• Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A
  “The clinical trial was withdrawn due to a commercial decision.” (57% match in meaning)
• A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors
  “The trial was terminated for strategic reasons. The decision was not based on any safety and/or efficacy concerns.” (57% match in meaning)
• Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer
  “The clinical trial has been terminated due to the revocation of funding. Although one subject was enrolled, the participant withdrew prior to receiving any treatment. No trial-related procedures generating evaluable clinical data were performed.” (56% match in meaning)
• Transanal Resection of Rectal Lesions With the ColubrisMX ELS System
  “Terminated by ColubrisMX due to its identification of irregularities in the conduct of the trial (not related to clinical safety or effectiveness of the device)” (56% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.